Arlington, TX, United States of America

Yong He


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Antibiotic Development by Yong He

Introduction

Yong He is an accomplished inventor based in Arlington, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotic compounds. With a total of 2 patents to his name, his work focuses on addressing the challenges posed by drug-resistant microorganisms.

Latest Patents

Yong He's latest patents include innovative rifamycin derivatives. These compounds are characterized by their unique chemical structures, which exhibit valuable antibiotic properties. The first patent details novel rifamycin derivatives of formula I, including both hydroquinone and corresponding quinone forms. These compounds can be utilized in the control or prevention of infectious diseases in mammals, demonstrating pronounced antibacterial activity against multiresistant strains of microbes. The second patent describes (R/S) rifamycin derivatives, their preparations, and pharmaceutical compositions. These derivatives also show antimicrobial activities, including effectiveness against drug-resistant microorganisms.

Career Highlights

Yong He is currently associated with Cumbre Pharmaceuticals Inc., where he continues to innovate in the field of antibiotic research. His work is pivotal in developing new formulations that can combat infectious diseases, contributing to public health advancements.

Collaborations

Yong He collaborates with notable colleagues, including Zhenkun Ma and Jing Li. Their combined expertise enhances the research and development efforts at Cumbre Pharmaceuticals Inc.

Conclusion

Yong He's contributions to antibiotic development through his innovative patents are crucial in the fight against infectious diseases. His work not only addresses current health challenges but also paves the way for future advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…